Mitsubishi UFJ Trust & Banking Corp Has $24.76 Million Holdings in The Clorox Company $CLX

Mitsubishi UFJ Trust & Banking Corp cut its position in shares of The Clorox Company (NYSE:CLX) by 34.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 200,837 shares of the company’s stock after selling 105,004 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in Clorox were worth $24,763,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Savvy Advisors Inc. increased its holdings in Clorox by 1.4% in the 2nd quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock valued at $768,000 after buying an additional 91 shares during the period. Canandaigua National Bank & Trust Co. boosted its position in shares of Clorox by 0.8% during the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock valued at $1,380,000 after acquiring an additional 94 shares in the last quarter. State of Michigan Retirement System increased its stake in Clorox by 0.3% in the second quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock valued at $4,028,000 after acquiring an additional 100 shares during the period. Blue Trust Inc. raised its position in Clorox by 8.5% in the third quarter. Blue Trust Inc. now owns 1,333 shares of the company’s stock worth $164,000 after purchasing an additional 104 shares in the last quarter. Finally, Westhampton Capital LLC lifted its stake in Clorox by 0.5% during the third quarter. Westhampton Capital LLC now owns 23,150 shares of the company’s stock worth $2,854,000 after purchasing an additional 107 shares during the period. 78.53% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. lowered their price objective on Clorox from $120.00 to $114.00 and set a “neutral” rating on the stock in a research note on Friday, January 16th. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a research report on Saturday. The Goldman Sachs Group cut their price objective on Clorox from $110.00 to $94.00 and set a “sell” rating for the company in a report on Wednesday, January 7th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a report on Friday, January 9th. Finally, Rothschild & Co Redburn cut their price target on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. One equities research analyst has rated the stock with a Buy rating, thirteen have given a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $122.19.

Insider Activity

In related news, Director Pierre R. Breber purchased 4,000 shares of the firm’s stock in a transaction dated Friday, November 21st. The shares were acquired at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.63% of the company’s stock.

Clorox Trading Down 0.6%

Shares of CLX opened at $112.84 on Tuesday. The company has a debt-to-equity ratio of 18.01, a quick ratio of 0.50 and a current ratio of 0.76. The company has a market cap of $13.76 billion, a price-to-earnings ratio of 17.71, a PEG ratio of 0.57 and a beta of 0.58. The stock has a fifty day moving average price of $104.03 and a two-hundred day moving average price of $114.60. The Clorox Company has a 52-week low of $96.66 and a 52-week high of $164.22.

Clorox (NYSE:CLX) last announced its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same period last year, the company posted $1.86 earnings per share. The firm’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.4%. Clorox’s payout ratio is currently 77.86%.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.